Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Thyroid Tests Influenced by Cholesterol-Lowering Statins

By LabMedica International staff writers
Posted on 26 Feb 2009
Scientists have discovered that cholesterol-lowering statins, used to treat and prevent atherosclerosis, may falsely indicate thyroid problems.

Investigators reexamined 307 patients whose initial TSH blood tests, the most common measure of thyroid function, showed overactive thyroids. More...
Symptoms of the condition, called hyperthyroidism, include a fast heart rate and palpitations, tremors, anxiety, weak muscles, and difficulty sleeping.

More specialized diagnostics with radioactive iodine were used in the new study than the previous simple TSH tests. These new tests showed that the majority of patients on statins who appeared to be hyperthyroid by TSH tests actually had normal thyroid function. The tests also confirmed that the majority of patients not taking statins did have thyroid problems, as the initial TSH tests suggested.

"These findings could help physicians make quicker, more accurate diagnoses of suspected thyroid problems," said Dr. William Harvey, a nuclear medicine physician and author of the study. "It also has very provocative scientific implications as we learn more about how statins affect different systems in the body."

Hyperthyroidism affects about 4 million people in the United States. Graves' disease is the most common form of the condition, which occurs when the body's immune system mistakenly attacks the thyroid gland.

Dr. Mark Feldman, chairman of internal medicine at Texas Health Dallas (USA) and the study's senior author, said, "These findings are fascinating because there's a possibility that statins may improve thyroid function in patients with overactive thyroids."

The study appeared in the October 2008 issue of the journal Thyroid.

Texas Health Dallas


Related Links:

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
Repetitive Pipette
VWR® Stepper Pro
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The study compares rapid molecular CPE diagnostics, which can return results in about one hour, with culture-based screening, which typically takes about 48 hours (Image credit: Adobe Stock)

Rapid Molecular Screening Aims to Accelerate Hospital Infection Control for CPE

Drug-resistant infections remain a critical patient-safety threat in hospitals, with carbapenemase-producing Enterobacterales (CPE) among the most urgent concerns. In England, reports of acquired carbapenemase... Read more

Pathology

view channel
Image: The VENTANA PTEN (SP218) RxDx Assay is a qualitative IHC assay for assessing PTEN protein in prostate adenocarcinoma, with staining performed using the OptiView DAB IHC Detection Kit on a BenchMark ULTRA instrument (Photo courtesy of Roche)

New Companion Diagnostic Expands Precision Medicine in Prostate Cancer

Prostate cancer is a leading cancer diagnosis in men and becomes particularly aggressive when it presents as metastatic, hormone-sensitive disease. Tumors with loss of phosphatase and tensin homolog (PTEN)... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.